SCAI issues position statement on the performance of percutaneous coronary intervention in ambulatory surgical centers

May 14, 2020

WASHINGTON - The Society for Cardiovascular Angiography and Interventions (SCAI) today issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs). The document was published in SCAI's official journal, Catheterization and Cardiovascular Interventions.

Earlier this year, The Centers for Medicare & Medicaid Services (CMS) began reimbursement for PCI performed in ASCs in response to data on patient outcomes from observational studies and randomized controlled trials supporting same-day discharge (SDD) after PCI.

"One of the biggest stories in interventional cardiology this past year was the initiation of payment by CMS for PCI performed in ambulatory surgical centers or ASC," said Lyndon Box, MD, FSCAI, chair of the writing group and interventional cardiologist at West Valley Cardiology Services in Idaho. "SCAI recognized the potential for this new rule to decrease cost, improve patient satisfaction and increase physician autonomy."

The position statement makes recommendations for facility and equipment standards, procedural and periprocedural standards, transfer protocols, and operator standards based on an examination of the evidence for potential benefits and harms. The statement also provides an overview for operators on regulatory considerations.

When defining appropriate treatment in the ASC, the writing groups suggests that diagnostic procedures (ie. left and right heart catheterization, coronary and graft angiography) are appropriate for ASCs. Invasive diagnostic testing that involves intravascular imaging (IVUS and/or OCT) or functional evaluation (FFR and/or resting indices) and coronary angioplasty and stenting were also deemed appropriate.

Notably, the document advises that only patients who are considered appropriate for SDD should be considered for intervention in an ASC. The 2018 SCAI Expert Consensus Document on Length of Stay Following PCI provides guidance on patient suitability for SDD. Additionally, the writing groups suggests that not all patients that might be suitable for SDD in the hospital setting are appropriate for ASC-based PCI, stating that the ASC setting does not provide the option of easily converting a patient to overnight observation. PCI in patients with high-risk clinical features should be avoided in the ASC setting.

The document concludes that the decision to perform PCI in an ASC should be made in the context of the local healthcare environment, while initiation of an ASC PCI program should require transparent adherence to state and federal regulations and operational standards.

"It is crucial that patients in the ASC receive the same quality of care as those in the hospital setting. The paper covers regulatory issues, standards, protocols, quality assurance and ethics. This paper is a 'must-read' for anyone involved with PCI in an ASC," said Box.
-end-
Session Details: "VIRTUAL: SCAI Clinical Documents". SCAI 2020 Scientific Sessions Virtual Conference, May 14, 2020 at 1:30 pm ET.

About the Society for Cardiovascular Angiography and Interventions

The Society for Cardiovascular Angiography and Interventions (SCAI) is a professional member organization representing 5,000 invasive and interventional cardiologists in approximately 75 nations. SCAI's mission is to promote excellence invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. For more information about SCAI, visit http://www.scai.org and http://www.secondscount.org. Follow @SCAI on Twitter for the latest heart health news.

Society for Cardiovascular Angiography and Interventions

Related Percutaneous Coronary Intervention Articles from Brightsurf:

A bypass route for the coronary vessels in the heart?
When the heart develops, some of its coronary blood vessels develop from cells lining the inner surface of the heart's ventricular chambers (endocardium).

Amgen announces new FOURIER analysis showing Repatha® (evolocumab) reduced cardiovascular events in patients with prior percutaneous intervention at AHA 2020
Amgen (NASDAQ:AMGN) today announced a new analysis from the Repatha® (evolocumab) cardiovascular (CV) outcomes study (FOURIER) that evaluated the effectiveness of Repatha in atherosclerotic cardiovascular disease (ASCVD) patients on statin therapy with prior percutaneous coronary intervention (PCI), also known as coronary angioplasty.

Ultrasound-guided percutaneous needle biopsy excellent for small pleural lesions diagnosis
According to an open-access article in ARRS' American Journal of Roentgenology, ultrasound (US)-guided percutaneous pleural needle biopsy (PCPNB) has excellent diagnostic accuracy for small pleural lesions.

For toddlers with autism, more intervention hours are not necessarily better
Two prominent early intervention models for toddlers with autism show a very similar impact, whether delivered at 15-hours or 25-hours per week intensities, a UC Davis MIND Institute study has found.

Minimally invasive percutaneous treatment for osteoid osteoma of the spine
Osteoid osteomas are benign but painful bone-forming tumors usually involving long bones, with localization at the spine in 10-20% of the cases.

SCAI issues position statement on the performance of percutaneous coronary intervention in ambulatory surgical centers
The Society for Cardiovascular Angiography and Interventions (SCAI) today issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs).

SCAI releases official position statement on optimal percutaneous interventional therapy for complex coronary artery disease
The Society for Cardiovascular Angiography and Interventions (SCAI) has published a position statement addressing optimal percutaneous coronary intervention (PCI) treatment of patients with complex coronary artery disease (CAD).

Does coronary microvascular spasm exist?
In a new publication from Cardiovascular Innovations and Applications; Fabian Guenther, Andreas Seitz, Valeria Martínez Pereyra, Raffi Bekeredjian, Udo Sechtem and Peter Ong from the Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany consider whether coronary microvascular spasm exists.

Impact of postdilation on intervention success and MACE
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0564, the authors consider the impact of postdilation on intervention success and long-term major adverse cardiovascular events (MACE) among patients with acute coronary syndromes.

The relationship between mean platelet volume and in-hospital mortality in geriatric patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Read More: Percutaneous Coronary Intervention News and Percutaneous Coronary Intervention Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.